Literature DB >> 3768258

Urinary metabolites of caffeine in pregnant women.

N R Scott, J Chakraborty, V Marks.   

Abstract

In a study of caffeine and its metabolites in pregnant and non-pregnant women, on average 56.8% of the administered caffeine dose was recovered in the urine in both groups. However, compared to the controls, the pregnant subjects produced smaller amounts of 1-methylxanthine and 1-methyluric acid, whereas the excretion of most of the other metabolites, particularly 3,7-dimethylxanthine and 3-methylxanthine tended to be greater. It is suggested that hormonal influences on the hepatic caffeine metabolising enzymes might be implicated.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3768258      PMCID: PMC1401148          DOI: 10.1111/j.1365-2125.1986.tb02920.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  11 in total

1.  Hormonal regulation of drug metabolism during pregnancy.

Authors:  G Feuer; R Kardish
Journal:  Int J Clin Pharmacol Biopharm       Date:  1975-06

2.  Determination of the urinary metabolites of caffeine and theophylline by high-performance liquid chromatography. A comparative study of a direct injection and an ion-pair extraction procedure.

Authors:  N R Scott; J Chakraborty; V Marks
Journal:  J Chromatogr       Date:  1986-03-07

3.  Some alterations in the pattern of drug metabolism aociated with pegnancy, oral contraceptives, and the newly-born.

Authors:  J S Crawford; S Rudofsky
Journal:  Br J Anaesth       Date:  1966-06       Impact factor: 9.166

4.  Comparison of caffeine metabolism in three nonsmoking populations after oral administration of radiolabeled caffeine.

Authors:  M M Callahan; R S Robertson; A R Branfman; M F McComish; D W Yesair
Journal:  Drug Metab Dispos       Date:  1983 May-Jun       Impact factor: 3.922

5.  Phenytoin and phenobarbitone plasma clearance during pregnancy.

Authors:  K I Mygind; M Dam; J Christiansen
Journal:  Acta Neurol Scand       Date:  1976-08       Impact factor: 3.209

6.  The disposition of caffeine during and after pregnancy.

Authors:  A Aldridge; J Bailey; A H Neims
Journal:  Semin Perinatol       Date:  1981-10       Impact factor: 3.300

7.  Hepatic microsomal drug metabolism in the pregnant rat.

Authors:  A M Symons; R G Turcan; D V Parke
Journal:  Xenobiotica       Date:  1982-06       Impact factor: 1.908

8.  Effects of ethinyl estradiol on hepatic microsomal proteins and the turnover of cytochrome P-450.

Authors:  M Mackinnon; E Sutherland; F R Simon
Journal:  J Lab Clin Med       Date:  1977-12

9.  The effect of pregnancy on the pharmacokinetics of caffeine.

Authors:  R Knutti; H Rothweiler; C Schlatter
Journal:  Arch Toxicol Suppl       Date:  1982

10.  Inhibition of hepatic drug metabolism by norethindrone.

Authors:  B Field; C Lu; G W Hepner
Journal:  Clin Pharmacol Ther       Date:  1979-02       Impact factor: 6.875

View more
  3 in total

1.  Effects of moderate exercise on the pharmacokinetics of caffeine.

Authors:  K Collomp; F Anselme; M Audran; J P Gay; J L Chanal; C Prefaut
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

2.  Urinary caffeine metabolites in man. Age-dependent changes and pattern in various clinical situations.

Authors:  D Ullrich; D Compagnone; B Münch; A Brandes; H Hille; J Bircher
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

3.  Direct conversion of theophylline to 3-methylxanthine by metabolically engineered E. coli.

Authors:  Khalid H R Algharrawi; Ryan M Summers; Sridhar Gopishetty; Mani Subramanian
Journal:  Microb Cell Fact       Date:  2015-12-21       Impact factor: 5.328

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.